Table 4 Incremental cost of ART service use, compared between different levels of service
From: Economic evaluation of task-shifting approaches to the dispensing of anti-retroviral therapy
Level of service | Average number of patient visits per year | Cost to provider | Cost to patient | Societal cost | Average annual cost per patient for baseline, incremental cost for other models |
|---|---|---|---|---|---|
| Â | Â | Average cost to provider per visit for baseline, incremental cost for other models | Average cost to patient per visit for baseline, incremental cost for other models | Average cost to society per visit for baseline, incremental cost for other models | Â |
Full-time pharmacist (baseline) | 7.78 | US$ 6.55 | US$ 10.04 | US$16.58 | US$128.99 |
ISPA | 10.74 | -US$ 0.81 | -US$ 2.60 | -US$3.40 | US$12.56 |
Nurse | 9.78 | US$ 3.61 | -US$ 3.75 | -US$0.13 | US$31.89 |